Myasthenia gravis and related disorders

Pathology and molecular pathogenesis

James C. Ha, David P Richman

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Disorders affecting the presynaptic, synaptic, and postsynaptic portions of the neuromuscular junction arise from various mechanisms in children and adults, including acquired autoimmune or toxic processes as well as genetic mutations. Disorders include autoimmune myasthenia gravis associated with acetylcholine receptor, muscle specific kinase or Lrp4 antibodies, Lambert-Eaton myasthenic syndrome, nerve terminal hyperexcitability syndromes, Guillain Barré syndrome, botulism, organophosphate poisoning and a number of congenital myasthenic syndromes. This review focuses on the various molecular and pathophysiological mechanisms of these disorders, characterization of which has been crucial to the development of treatment strategies specific for each pathogenic mechanism. In the future, further understanding of the underlying processes may lead to more effective and targeted therapies of these disorders. This article is part of a Special Issue entitled: Neuromuscular Diseases: Pathology and Molecular Pathogenesis.

Original languageEnglish (US)
Pages (from-to)651-657
Number of pages7
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1852
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Molecular Pathology
Myasthenia Gravis
Congenital Myasthenic Syndromes
Lambert-Eaton Myasthenic Syndrome
Organophosphate Poisoning
Botulism
Neuromuscular Diseases
Neuromuscular Junction
Poisons
Cholinergic Receptors
Phosphotransferases
Muscles
Mutation
Antibodies
Therapeutics

Keywords

  • Botulism
  • Congenital myasthenic syndrome
  • Lambert-Eaton myasthenic syndrome
  • Myasthenia gravis
  • Neuromuscular junction
  • Organophosphate poisoning

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine

Cite this

Myasthenia gravis and related disorders : Pathology and molecular pathogenesis. / Ha, James C.; Richman, David P.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1852, No. 4, 01.04.2015, p. 651-657.

Research output: Contribution to journalArticle

@article{92c20ffc904a46a2876f924a756621e0,
title = "Myasthenia gravis and related disorders: Pathology and molecular pathogenesis",
abstract = "Disorders affecting the presynaptic, synaptic, and postsynaptic portions of the neuromuscular junction arise from various mechanisms in children and adults, including acquired autoimmune or toxic processes as well as genetic mutations. Disorders include autoimmune myasthenia gravis associated with acetylcholine receptor, muscle specific kinase or Lrp4 antibodies, Lambert-Eaton myasthenic syndrome, nerve terminal hyperexcitability syndromes, Guillain Barr{\'e} syndrome, botulism, organophosphate poisoning and a number of congenital myasthenic syndromes. This review focuses on the various molecular and pathophysiological mechanisms of these disorders, characterization of which has been crucial to the development of treatment strategies specific for each pathogenic mechanism. In the future, further understanding of the underlying processes may lead to more effective and targeted therapies of these disorders. This article is part of a Special Issue entitled: Neuromuscular Diseases: Pathology and Molecular Pathogenesis.",
keywords = "Botulism, Congenital myasthenic syndrome, Lambert-Eaton myasthenic syndrome, Myasthenia gravis, Neuromuscular junction, Organophosphate poisoning",
author = "Ha, {James C.} and Richman, {David P}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.bbadis.2014.11.022",
language = "English (US)",
volume = "1852",
pages = "651--657",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Myasthenia gravis and related disorders

T2 - Pathology and molecular pathogenesis

AU - Ha, James C.

AU - Richman, David P

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Disorders affecting the presynaptic, synaptic, and postsynaptic portions of the neuromuscular junction arise from various mechanisms in children and adults, including acquired autoimmune or toxic processes as well as genetic mutations. Disorders include autoimmune myasthenia gravis associated with acetylcholine receptor, muscle specific kinase or Lrp4 antibodies, Lambert-Eaton myasthenic syndrome, nerve terminal hyperexcitability syndromes, Guillain Barré syndrome, botulism, organophosphate poisoning and a number of congenital myasthenic syndromes. This review focuses on the various molecular and pathophysiological mechanisms of these disorders, characterization of which has been crucial to the development of treatment strategies specific for each pathogenic mechanism. In the future, further understanding of the underlying processes may lead to more effective and targeted therapies of these disorders. This article is part of a Special Issue entitled: Neuromuscular Diseases: Pathology and Molecular Pathogenesis.

AB - Disorders affecting the presynaptic, synaptic, and postsynaptic portions of the neuromuscular junction arise from various mechanisms in children and adults, including acquired autoimmune or toxic processes as well as genetic mutations. Disorders include autoimmune myasthenia gravis associated with acetylcholine receptor, muscle specific kinase or Lrp4 antibodies, Lambert-Eaton myasthenic syndrome, nerve terminal hyperexcitability syndromes, Guillain Barré syndrome, botulism, organophosphate poisoning and a number of congenital myasthenic syndromes. This review focuses on the various molecular and pathophysiological mechanisms of these disorders, characterization of which has been crucial to the development of treatment strategies specific for each pathogenic mechanism. In the future, further understanding of the underlying processes may lead to more effective and targeted therapies of these disorders. This article is part of a Special Issue entitled: Neuromuscular Diseases: Pathology and Molecular Pathogenesis.

KW - Botulism

KW - Congenital myasthenic syndrome

KW - Lambert-Eaton myasthenic syndrome

KW - Myasthenia gravis

KW - Neuromuscular junction

KW - Organophosphate poisoning

UR - http://www.scopus.com/inward/record.url?scp=84922272748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922272748&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2014.11.022

DO - 10.1016/j.bbadis.2014.11.022

M3 - Article

VL - 1852

SP - 651

EP - 657

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 4

ER -